Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1513 results found
2022 ∙ SeyedAlinaghi, S. Karimi, A. Pashaei, Z. Afzalian, A. Mirzapour, P. Ghorbanzadeh, K. Ghasemzadeh, A. Dashti, M. Nazarian, N. Vahedi, F. Tantuoyir, M. M. Shamsabadi, A. Dadras, O. Mehraeen, E.
Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review
Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Dadras, O. Mehraeen, E. Karimi, A. Tantuoyir, M. M. Afzalian, A. Nazarian, N. Mojdeganlou, H. Mirzapour, P. Shamsabadi, A. Dashti, M. Ghasemzadeh, A. Vahedi, F. Shobeiri, P. Pashaei, Z. SeyedAlinaghi, S.
Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax;a Systematic Review
All age groups COVID-19 Safety
Rating:
Critically low
2022 ∙ Mehta, N. Shah, S. Paudel, K. Chamlagain, R. Chhetri, S.
Safety and efficacy of coronavirus disease-19 vaccines in chronic kidney disease patients under maintenance hemodialysis: A systematic review
Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Tian, F. Yang, R.
Safety and Efficacy of COVID-19 Vaccines in Children and Adolescents: a Systematic Review of Randomized Controlled Trials
Newborn Children COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Xu, W. Tang, J. Chen, C. Wang, C. Wen, W. Cheng, Y. Zhou, M. Wu, Q. Zhang, X. Feng, Z. Wang, M.
Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis
Children Adolescents COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Katoto, P. D. M. C. Brand, A. S. Byamungu, L. N. Tamuzi, J. L. Mahwire, T. C. Kitenge, M. K. Wiysonge, C. S. Gray, G.
Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis
Adolescents COVID-19 Safety
Rating:
Critically low
2022 ∙ Chen, H. Zhang, X. Lin, G. Gong, F. Hocher, B.
Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - Clinical study and systematic review
Western Pacific China Adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Zheng, Q. Ma, P. Feng, Z.
Safety of COVID-19 vaccine in patients with epilepsy: a meta-analysis
All age groups COVID-19 Safety
Rating:
Critically low
2022 ∙ James, D. Jena, A. Bharath, P. N. Choudhury, A. Singh, A. K. Sebastian, S. Sharma, V.
Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis
All age groups COVID-19 Safety
Rating:
Low
2022 ∙ Asghar, N. Mumtaz, H. Syed, A. A. Eqbal, F. Maharjan, R. Bamboria, A. Shrehta, M.
Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
Loading...